Form 4 for INTS INTENSITY THERAPEUTICS, INC.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0001895944-24-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-07 | 2024-06-05 | INTS | Wesolowski John M | Principal Accounting Off | M - OptEx | $4.00 | +1,000 | 6,691 | +18% | +$4,000 |
| D | 2024-06-07 | 2024-06-05 | INTS | Wesolowski John M | Principal Accounting Off | M - OptEx | $0.00 | -1,000 | 14.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 Par Value | 2024-06-05 | M | A | 1,000 | $4.00 | 6,691 | D | — | — | (F1) Due to an inadvertent error, the Form 3 filed by the Reporting Person on June 29, 2023 incorrectly reported the amount of securities beneficially owned. This inadvertent error caused the amount of securities beneficially owned to be understated by 691 shares. The new amount reported in Column 5 reports the correct amount of securities beneficially owned following the reported transaction. |
| 2 | Derivative | Stock Option (right to buy Common Stock) | 2024-06-05 | M | D | 1,000 | $0.00 | 14,000 | D | $4.00 · — to 2027-03-27 | 1,000 Common Stock | (F2) This option is fully vested and exercisable as of March 27, 2021. |